chr1-218386133-C-A
Variant names: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_003238.6(TGFB2):c.347-19036C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.545 in 152,026 control chromosomes in the GnomAD database, including 26,138 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.55   (  26138   hom.,  cov: 32) 
Consequence
 TGFB2
NM_003238.6 intron
NM_003238.6 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  -0.722  
Publications
10 publications found 
Genes affected
 TGFB2  (HGNC:11768):  (transforming growth factor beta 2) This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate a latency-associated peptide (LAP) and a mature peptide, and is found in either a latent form composed of a mature peptide homodimer, a LAP homodimer, and a latent TGF-beta binding protein, or in an active form consisting solely of the mature peptide homodimer. The mature peptide may also form heterodimers with other TGF-beta family members. Disruption of the TGF-beta/SMAD pathway has been implicated in a variety of human cancers. A chromosomal translocation that includes this gene is associated with Peters' anomaly, a congenital defect of the anterior chamber of the eye. Mutations in this gene may be associated with Loeys-Dietz syndrome. This gene encodes multiple isoforms that may undergo similar proteolytic processing. [provided by RefSeq, Aug 2016] 
TGFB2 Gene-Disease associations (from GenCC):
- familial thoracic aortic aneurysm and aortic dissectionInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
 - Loeys-Dietz syndrome 4Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), PanelApp Australia, G2P
 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88). 
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.694  is higher than 0.05. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| TGFB2 | NM_003238.6  | c.347-19036C>A | intron_variant | Intron 1 of 6 | ENST00000366930.9 | NP_003229.1 | ||
| TGFB2 | NM_001135599.4  | c.431-19036C>A | intron_variant | Intron 2 of 7 | NP_001129071.1 | |||
| TGFB2 | NR_138148.2  | n.1713-19036C>A | intron_variant | Intron 1 of 6 | ||||
| TGFB2 | NR_138149.2  | n.1797-19036C>A | intron_variant | Intron 2 of 7 | 
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| TGFB2 | ENST00000366930.9  | c.347-19036C>A | intron_variant | Intron 1 of 6 | 1 | NM_003238.6 | ENSP00000355897.4 | |||
| TGFB2 | ENST00000366929.4  | c.431-19036C>A | intron_variant | Intron 2 of 7 | 1 | ENSP00000355896.4 | ||||
| TGFB2 | ENST00000488793.1  | n.11-19036C>A | intron_variant | Intron 1 of 2 | 3 | 
Frequencies
GnomAD3 genomes   AF:  0.545  AC: 82863AN: 151908Hom.:  26138  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
82863
AN: 
151908
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome   AF:  0.545  AC: 82884AN: 152026Hom.:  26138  Cov.: 32 AF XY:  0.548  AC XY: 40733AN XY: 74296 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
82884
AN: 
152026
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
40733
AN XY: 
74296
show subpopulations 
African (AFR) 
 AF: 
AC: 
8692
AN: 
41492
American (AMR) 
 AF: 
AC: 
9713
AN: 
15282
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
2264
AN: 
3468
East Asian (EAS) 
 AF: 
AC: 
2531
AN: 
5126
South Asian (SAS) 
 AF: 
AC: 
2655
AN: 
4814
European-Finnish (FIN) 
 AF: 
AC: 
7417
AN: 
10566
Middle Eastern (MID) 
 AF: 
AC: 
171
AN: 
290
European-Non Finnish (NFE) 
 AF: 
AC: 
47520
AN: 
67968
Other (OTH) 
 AF: 
AC: 
1216
AN: 
2110
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.500 
Heterozygous variant carriers
 0 
 1599 
 3198 
 4798 
 6397 
 7996 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 696 
 1392 
 2088 
 2784 
 3480 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
1849
AN: 
3478
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.